Valo Therapeutics logo

Valo Therapeutics

Immunooncology platform developing tumor antigen-coated oncolytic viruses as therapeutic vaccines.

4

Funding Rounds

$46.7m

Money raised

Overview

Immunooncology platform developing tumor antigen-coated oncolytic viruses as therapeutic vaccines.

Funding

Funding series

Funding Series Analysis

The company Valo Therapeutics has raised a total of $46.7m in funding over 4 rounds.

Key Insights:

  • Valo Therapeutics Series A Round, March 2025: $20m
  • Valo Therapeutics , November 2021: $12.5m
  • Valo Therapeutics November 2021 Funding Round: $13m
  • Valo Therapeutics , February 2020: $1.2m
Valo Therapeutics logo
Valo Therapeutics Series A Round, March 2025 $20m
Valo Therapeutics logo
Valo Therapeutics , November 2021 $12.5m
Valo Therapeutics logo
Valo Therapeutics November 2021 Funding Round $13m
Valo Therapeutics logo
Valo Therapeutics , February 2020 $1.2m